12:00 AM
 | 
Sep 27, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Recombinant adeno-associated virus regulatory update

AVGN received U.S. Patent No. 5,952,221 covering AAV vectors carrying therapeutic genes to treat cancer along...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >